News Sentiment

TEM sentiment intelligence

Tempus AI, Inc. Class A Common Stock news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 75 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Health Information Services Read-through group
Latest close 58.23 Week of 10 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

87/100 classification confidence.

Company focus 75

directly relevant articles

Source quality 3

high-authority source matches

Trend context Trend inactive

-3.4% over one week, +21.8% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 87/100 classification
One-week reaction -3.4% Price reacting lower
Trend fit Trend inactive 21.8% over four weeks
Fair value 1.5% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 48
Negative 11

Relevance

Why the article matched

Direct first
Direct company coverage 75
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 11
Market source 11
MarketBeat 7
TradingView 4
Business Wire 3
Investing.com 3
Insider Monkey 3
Quiver Quantitative 2

Event Lens

What the news is about

Classified themes
Market update 59
Earnings 10
Analyst action 6

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 75
The Globe and Mail Direct company coverage

Morgan Stanley Remains a Buy on Tempus AI, Inc. Class A (TEM)

Morgan Stanley analyst Kallum Titchmarsh has reiterated a Buy rating on Tempus AI, Inc. Class A (TEM) and set a price target of $70.00. This recommendation comes despite the company reporting an increased GAAP net loss in its latest quarterly earnings, though revenue also grew si

Tone
Positive 77/100
Event
Analyst action
Published
11 Jul 2026 11:11
Source
The Globe and Mail
Investing.com Nigeria Direct company coverage

Tempus AI’s Ryan Fukushima, CEO, data, sells $1.91m in stock

Ryan Fukushima, CEO of Data at Tempus AI (NASDAQ:TEM), indirectly sold Class A Common Stock worth approximately $1.91 million on July 8, 2026, through his spouse's Rule 10b5-1 trading plan. These sales involved 33,284 shares at prices ranging from $56.80 to $59.47. Following thes

Tone
Negative 38/100
Event
Market update
Published
11 Jul 2026 10:12
Source
Investing.com Nigeria
Investing.com South Africa Direct company coverage

Tempus AI’s Ryan Fukushima, CEO, data, sells $1.91m in stock By Investing.com

Ryan Fukushima, CEO of Data at Tempus AI, sold approximately $1.91 million worth of Class A Common Stock on July 8, 2026, through transactions made by his spouse under a Rule 10b5-1 trading plan. The sale involved 33,284 shares at weighted average prices between $56.80 and $59.47

Tone
Negative 37/100
Event
Market update
Published
10 Jul 2026 22:11
Source
Investing.com South Africa
Stock Titan Direct company coverage

Tempus AI (TEM) officer logs 33,284-share spouse sale under Rule 10b5-1 plan

Ryan Fukushima, an officer at Tempus AI (TEM), reported that his spouse sold 33,284 shares of Class A Common Stock on July 8, 2026, under a Rule 10b5-1 trading plan. The sales occurred at weighted average prices between $56.80 and $59.47 per share. Following these transactions, F

Tone
Negative 37/100
Event
Market update
Published
10 Jul 2026 20:40
Source
Stock Titan
Stock Titan Direct company coverage

Rule 10b5-1 sale by Tempus AI (TEM) officer’s spouse trims holdings

The spouse of Tempus AI officer Fukushima Ryan sold 10,000 shares of Class A Common Stock at $60 per share under a pre-arranged Rule 10b5-1 trading plan. After this transaction, the spouse indirectly holds 201,047 shares, while Fukushima Ryan directly holds 603,558 shares. This s

Tone
Negative 37/100
Event
Market update
Published
08 Jul 2026 20:40
Source
Stock Titan
Investing.com Canada Direct company coverage

Tempus AI CEO, data Fukushima sells $600,000 in stock By Investing.com

Ryan Fukushima, Tempus AI's CEO of Data, recently sold 10,000 shares of the company's Class A Common Stock for $600,000. The transaction, on July 6, 2026, was executed under a Rule 10b5-1 trading plan. The sale occurred when TEM's stock was at $60.0, and has since declined to $57

Tone
Negative 41/100
Event
Market update
Published
08 Jul 2026 04:20
Source
Investing.com Canada
Stock Titan Direct company coverage

CEO Eric Lefkofsky entities sell 166,250 Tempus AI (TEM) shares under 10b5-1 plan

Entities associated with Tempus AI CEO and Chairman Eric P. Lefkofsky sold a total of 166,250 shares of Class A Common Stock on June 29, 2026. The sales were executed by Blue Media, LLC and Gray Media, LLC at weighted average prices between $54.82 and $59.59 per share, pursuant t

Tone
Negative 28/100
Event
Market update
Published
01 Jul 2026 20:40
Source
Stock Titan
Investing.com Australia Direct company coverage

Tempus AI CFO James Rogers sells $634,095 in TEM stock By Investing.com

Tempus AI, Inc.'s CFO, James William Rogers, sold 11,529 shares of Class A Common Stock for $634,095, executed under a Rule 10b5-1 trading plan. Despite the sale, Rogers still directly holds 114,866 shares. The company has recently engaged in research collaborations for angiosarc

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 10:46
Source
Investing.com Australia
Investing.com Direct company coverage

Tempus AI director Jennifer Doudna sells $147,015 in stock

Tempus AI director Jennifer Doudna sold 2,673 shares of Class A Common Stock for $147,015 on June 25, 2026, as part of a Rule 10b5-1 trading plan. Post-sale, Doudna retains 25,942 shares, and while the stock has surged, InvestingPro data suggests it is overvalued. Tempus AI has a

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 07:40
Source
Investing.com
Investing.com Australia Direct company coverage

Tempus AI director Jennifer Doudna sells $147,015 in stock By Investing.com

Tempus AI director Jennifer Doudna sold 2,673 shares of Class A Common Stock for $147,015 on June 25, 2026, as part of a Rule 10b5-1 trading plan. Despite the sale, the stock has seen a significant surge, though it is considered overvalued by InvestingPro. In other news, Tempus A

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 04:09
Source
Investing.com Australia
Stock Titan Direct company coverage

Tempus AI (TEM) CFO sells 11,529 shares under Rule 10b5-1 plan

Tempus AI, Inc.'s Chief Financial Officer, James William Rogers, reported an open-market sale of 11,529 shares of Class A Common Stock at $55.00 per share. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. Following the sal

Tone
Negative 39/100
Event
Market update
Published
30 Jun 2026 01:09
Source
Stock Titan
Stock Titan Direct company coverage

Tempus AI (TEM) director sells 2,673 shares under 10b5-1 plan

Tempus AI director Jennifer A. Doudna reported an open-market sale of 2,673 shares of Class A Common Stock at $55.00 per share on June 25, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted in August 2025. Following the sale, Doudna directly

Tone
Negative 39/100
Event
Market update
Published
30 Jun 2026 01:09
Source
Stock Titan
Stock Titan Direct company coverage

Tempus AI (NASDAQ: TEM) insiders report multi-holder Class A sales

A recent SEC Form 144 filing indicates that several insiders at Tempus AI (NASDAQ: TEM) have reported proposed sales of Class A Common Stock. The filing details multiple transactions from April to May 2026, including sales by Eric Lefkofsky and related entities Blue Media, LLC an

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 22:09
Source
Stock Titan